v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
(Accumulated Deficit) Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Sep. 27, 2024   131,482,000      
Beginning balance at Sep. 27, 2024 $ 903,051 $ 1,315 $ 928,082 $ 2,565 $ (28,911)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income (Loss) 832     832  
Dividends Declared ($0.035 per common share) (4,610)     (4,610)  
Other Comprehensive Income (Loss) [1] (3,157)       (3,157)
Share-based compensation expense 5,180   5,180    
Issuance of common stock upon exercise of stock options or awards of restricted stock units (in shares)   219,000      
Issuance of common stock upon exercise of stock options or awards of restricted stock units 2 $ 2      
Tax payments related to shares withheld for share based compensation plans (1,708)   (1,708)    
Ending balance (in shares) at Dec. 27, 2024   131,701,000      
Ending balance at Dec. 27, 2024 899,590 $ 1,317 931,554 (1,213) (32,068)
Beginning balance (in shares) at Sep. 27, 2024   131,482,000      
Beginning balance at Sep. 27, 2024 903,051 $ 1,315 928,082 2,565 (28,911)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income (Loss) (27,674)        
Other Comprehensive Income (Loss) 7,100        
Ending balance (in shares) at Jun. 27, 2025   131,837,000      
Ending balance at Jun. 27, 2025 882,228 $ 1,318 937,051 (34,330) (21,811)
Beginning balance (in shares) at Dec. 27, 2024   131,701,000      
Beginning balance at Dec. 27, 2024 899,590 $ 1,317 931,554 (1,213) (32,068)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income (Loss) (27,830)     (27,830)  
Dividends Declared ($0.035 per common share) (4,611)     (4,611)  
Other Comprehensive Income (Loss) 1,238       1,238
Share-based compensation expense 7,977   7,977    
Issuance of common stock upon exercise of stock options or awards of restricted stock units (in shares)   80,000      
Issuance of common stock upon exercise of stock options or awards of restricted stock units 0 $ 1 (1)    
Tax payments related to shares withheld for share based compensation plans (90)   (90)    
Ending balance (in shares) at Mar. 28, 2025   131,781,000      
Ending balance at Mar. 28, 2025 876,274 $ 1,318 939,440 (33,654) (30,830)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income (Loss) (676)     (676)  
Other Comprehensive Income (Loss) 9,019       9,019
Share-based compensation expense (2,148)   (2,148)    
Issuance of common stock upon exercise of stock options or awards of restricted stock units (in shares)   56,000      
Tax payments related to shares withheld for share based compensation plans (241)   (241)    
Ending balance (in shares) at Jun. 27, 2025   131,837,000      
Ending balance at Jun. 27, 2025 $ 882,228 $ 1,318 937,051 (34,330) (21,811)
Beginning balance (in shares) at Oct. 03, 2025 131,859,470 131,859,000      
Beginning balance at Oct. 03, 2025 $ 865,644 $ 1,319 937,531 (46,879) (26,327)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income (Loss) (6,391)     (6,391)  
Other Comprehensive Income (Loss) 3,172       3,172
Share-based compensation expense 2,343   2,343    
Issuance of common stock upon exercise of stock options or awards of restricted stock units (in shares)   115,000      
Issuance of common stock upon exercise of stock options or awards of restricted stock units 0 $ 1 (1)    
Tax payments related to shares withheld for share based compensation plans (340)   (340)    
Ending balance (in shares) at Jan. 02, 2026   131,974,000      
Ending balance at Jan. 02, 2026 $ 864,428 $ 1,320 939,533 (53,270) (23,155)
Beginning balance (in shares) at Oct. 03, 2025 131,859,470 131,859,000      
Beginning balance at Oct. 03, 2025 $ 865,644 $ 1,319 937,531 (46,879) (26,327)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income (Loss) 7,251        
Other Comprehensive Income (Loss) $ (3,623)        
Ending balance (in shares) at Jul. 03, 2026 132,156,745 132,157,000      
Ending balance at Jul. 03, 2026 $ 877,671 $ 1,322 945,927 (39,628) (29,950)
Beginning balance (in shares) at Jan. 02, 2026   131,974,000      
Beginning balance at Jan. 02, 2026 864,428 $ 1,320 939,533 (53,270) (23,155)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income (Loss) 2,596     2,596  
Other Comprehensive Income (Loss) (3,162)       (3,162)
Share-based compensation expense 3,374   3,374    
Issuance of common stock upon exercise of stock options or awards of restricted stock units (in shares)   128,000      
Issuance of common stock upon exercise of stock options or awards of restricted stock units 0 $ 1 (1)    
Tax payments related to shares withheld for share based compensation plans (34)   (34)    
Ending balance (in shares) at Apr. 03, 2026   132,102,000      
Ending balance at Apr. 03, 2026 867,202 $ 1,321 942,872 (50,674) (26,317)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income (Loss) 11,046     11,046  
Other Comprehensive Income (Loss) (3,633)       (3,633)
Share-based compensation expense 3,287   3,287    
Issuance of common stock upon exercise of stock options or awards of restricted stock units (in shares)   55,000      
Issuance of common stock upon exercise of stock options or awards of restricted stock units 0 $ 1 (1)    
Tax payments related to shares withheld for share based compensation plans $ (231)   (231)    
Ending balance (in shares) at Jul. 03, 2026 132,156,745 132,157,000      
Ending balance at Jul. 03, 2026 $ 877,671 $ 1,322 $ 945,927 $ (39,628) $ (29,950)
[1] Includes $9.5 million of cumulative currency translation adjustment that was derecognized as a result of the Company's sale of its equity method investment during the three months ended December 27, 2024.